Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Free radicals in chemical antioxidant assays are synthetic or naturally occurring reactive species employed in in vitro experiments to quantify the antioxidant potential of substances. These assays, such as the DPPH (2,2-diphenyl-1-picrylhydrazyl) or ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) tests, rely on the ability of a test compound to donate electrons or hydrogen atoms to neutralize the radical, typically resulting in a measurable color change (PMID: 23769221). While these specific chemical radicals are not therapeutic targets, they serve as models for endogenous reactive oxygen species (ROS) like superoxide and hydroxyl radicals that cause oxidative stress in vivo (PMID: 28249118). In biological systems, excessive free radical production is linked to cellular damage and the progression of diseases such as cancer, neurodegeneration, and cardiovascular disorders (PMID: 24511325). Antioxidant drugs and supplements interact with these species by scavenging them directly or by inducing protective enzymatic pathways to maintain redox homeostasis (PMID: 11327322). The use of these assays allows researchers to screen for potential therapeutic agents that can mitigate oxidative damage in clinical settings, although the correlation between in vitro capacity and in vivo efficacy remains a significant challenge.
Neutralization of reactive species through electron transfer (SET) or hydrogen atom transfer (HAT) mechanisms (PMID: 23769221).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Free radicals in chemical antioxidant assays.